GEN Magazine

Volume 42, Issue No. 10, October 2022

If you believe that a safe adventure is no adventure at all, you’ll be disappointed in the October issue of GEN. Again and again, it shows that great heights may be achieved even while risks are minimized. For example, our cover story describes how psychedelic drugs are becoming respectable. No more “bad trips.” In their place, we will see well-calibrated interventions for helping patients deal with addictions, mood disorders, and neurodegenerative diseases. Already, psychedelic drugs are more Daedalus than Icarus. The same spirit of calculated (but still bold) adventure animates other subjects in the current issue. Take gene therapy. Until recently, it was practically grounded due to safety concerns. But now, it is soaring from clinical trial to clinical trial. Scheduled flights suggest progress against hereditary monogenic disorders, complex diseases, and even cancer. The October issue also highlights well considered (but still rapid) progress in the manufacture of cell-based therapies, the storage and processing of biopharma data, and the analysis of cells by flow cytometry.

Browse the print magazine as a flipbook

Website Content from This Issue

Transforming Psychedelics into Approved Medicines

mock patient in bed

Gene Therapy Hits Its Stride in the Clinic

Adeno-associated viruses (AAV)

Five Startups Enliven the Gene Therapy Scene in Asia

Engineered RBCs

Drug Development Can Benefit from an Integrated Approach

R&D facility near Rome, Italy

Flow Cytometry Rides Successive Waves of Innovation

scientists at the Flow Cytometry Unit, Life Sciences Core Facilities

Biopharma Soars to the Computational Clouds

DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT Platform

Accelerating Gene Therapy Manufacturing with Integrated Solutions

iCELLis Nano bioreactor system

Will Manufacturing Be the Stumbling Block for T-Cell Therapies?

Thermo Fisher Scientific lab

Biobank-Tailored LIMS to Track Precious Samples and Manage Data

Making notes for her thesis

Synthetic Biology Platform Unleashes the Power of Plants

Close-up of green leaves

TCRs as Guidance Systems in Cancer Immunotherapy

BlueSphere Bio lab

High-Performance Microplates with Vertical Supply Chain Ownership

Aurora Hand and plate

Expanding GenScript ProBio’s CDMO Global Market

Antibody on DNA

Standalone Flow Chemistry Module for Exothermic Reactions

Uniqsis flow chem module

Motorized OpenStand Microscope Nosepieces

Prior Scientific

Reservoir for Sustainable Use of Reagents

Porvair Sciences

Antibodies for Preclinical and Clinical Drug Development

Bio-Rad Antibodies for Preclinical and Clinical Drug Development

Microscope Resolution

Microscope resolution

ESMO Interactive Guidelines




USMLE Immunology Flashcards


Team Says It Assembled the Most Complex Synthetic Microbiome

Synthetic Mouse Embryo with Brain and Beating Heart Grown from Stem Cells

Natural and synthetic embryos side by side

Cemvita Is Fighting Climate Change with Synthetic Biology

Power Plant in the sunrise